Literature DB >> 12558498

Structural requirements of human DNase II alpha for formation of the active enzyme: the role of the signal peptide, N-glycosylation, and disulphide bridging.

Kyle S MacLea1, Ronald J Krieser, Alan Eastman.   

Abstract

DNase II alpha (EC 3.1.22.1) is an endonuclease, which is active at low pH, that cleaves double-stranded DNA to short 3'-phosphoryl oligonucleotides. Although its biochemistry is well understood, its structure-activity relationship has been largely unexamined. Recently, we demonstrated that active DNase II alpha consists of one contiguous polypeptide, heavily glycosylated, and containing at least one intrachain disulphide linkage [MacLea, Krieser and Eastman (2002) Biochem. Biophys. Res. Commun. 292, 415-421]. The present paper describes further work to examine the elements of DNase II alpha protein required for activity. Truncated forms and site-specific mutants were expressed in DNase II alpha-null mouse cells. Results indicate that the signal-peptide leader sequence is required for correct glycosylation and that N-glycosylation is important for formation of the active enzyme. Despite this, enzymic deglycosylation of wild-type protein with peptide N-glycosidase F reveals that glycosylation is not intrinsically required for DNase activity. DNase II alpha contains six evolutionarily conserved cysteine residues, and mutations in any one of these cysteines completely ablated enzymic activity, consistent with the importance of disulphide bridging in maintaining correct protein structure. We also demonstrate that a mutant form of DNase II alpha that lacks the purported active-site His(295) can still bind DNA, indicating that this histidine residue is not simply involved in DNA binding, but may have a direct role in catalysis. These results provide a more complete model of the DNase II alpha protein structure, which is important for three-dimensional structural analysis and for production of DNase II alpha as a potential protein therapeutic for cystic fibrosis or other disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12558498      PMCID: PMC1223339          DOI: 10.1042/BJ20021875

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  STUDIES ON ACID DEOXYRIBONUCLEASE. II. ISOLATION AND CHARACTERIZATION OF SPLEEN-ACID DEOXYRIBONUCLEASE.

Authors:  G BERNARDI; M GRIFFE
Journal:  Biochemistry       Date:  1964-10       Impact factor: 3.162

2.  Revised structure of the active form of human deoxyribonuclease IIalpha.

Authors:  Kyle S MacLea; Ronald J Krieser; Alan Eastman
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

3.  The C. elegans apoptotic nuclease NUC-1 is related in sequence and activity to mammalian DNase II.

Authors:  C J Lyon; C J Evans; B R Bill; A J Otsuka; R J Aguilera
Journal:  Gene       Date:  2000-07-11       Impact factor: 3.688

4.  Deoxyribonuclease II: structure and chromosomal localization of the murine gene, and comparison with the genomic structure of the human and three C. elegans homologs.

Authors:  R J Krieser; A Eastman
Journal:  Gene       Date:  2000-07-11       Impact factor: 3.688

5.  Requirement of DNase II for definitive erythropoiesis in the mouse fetal liver.

Authors:  K Kawane; H Fukuyama; G Kondoh; J Takeda; Y Ohsawa; Y Uchiyama; S Nagata
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

6.  The cloning, genomic structure, localization, and expression of human deoxyribonuclease IIbeta.

Authors:  R J Krieser; K S MacLea; J P Park; A Eastman
Journal:  Gene       Date:  2001-05-16       Impact factor: 3.688

7.  Enzymatic active site of caspase-activated DNase (CAD) and its inhibition by inhibitor of CAD.

Authors:  H Sakahira; Y Takemura; S Nagata
Journal:  Arch Biochem Biophys       Date:  2001-04-01       Impact factor: 4.013

8.  NUC-1, a caenorhabditis elegans DNase II homolog, functions in an intermediate step of DNA degradation during apoptosis.

Authors:  Y C Wu; G M Stanfield; H R Horvitz
Journal:  Genes Dev       Date:  2000-03-01       Impact factor: 11.361

9.  Identification of functionally relevant histidine residues in the apoptotic nuclease CAD.

Authors:  G Meiss; S R Scholz; C Korn; O Gimadutdinow; A Pingoud
Journal:  Nucleic Acids Res       Date:  2001-10-01       Impact factor: 16.971

10.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

View more
  8 in total

1.  Identification of three crucial histidine residues (His115, His132 and His297) in porcine deoxyribonuclease II.

Authors:  Yu-Che Cheng; Chin-Chen Hsueh; Shao-Chun Lu; Ta-Hsiu Liao
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

2.  Human lysosomal DNase IIalpha contains two requisite PLD-signature (HxK) motifs: evidence for a pseudodimeric structure of the active enzyme species.

Authors:  Patrick Schäfer; Iwona A Cymerman; Janusz M Bujnicki; Gregor Meiss
Journal:  Protein Sci       Date:  2007-01       Impact factor: 6.725

Review 3.  The Role of Nucleases and Nucleic Acid Editing Enzymes in the Regulation of Self-Nucleic Acid Sensing.

Authors:  Pauline Santa; Anne Garreau; Lee Serpas; Amandine Ferriere; Patrick Blanco; Chetna Soni; Vanja Sisirak
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

4.  Autonomous and non-autonomous roles of DNase II during cell death in C. elegans embryos.

Authors:  Hsiang Yu; Huey-Jen Lai; Tai-Wei Lin; Szecheng J Lo
Journal:  Biosci Rep       Date:  2015-04-27       Impact factor: 3.840

5.  Type I interferon-mediated autoinflammation due to DNase II deficiency.

Authors:  Mathieu P Rodero; Alessandra Tesser; Eva Bartok; Gillian I Rice; Erika Della Mina; Marine Depp; Benoit Beitz; Vincent Bondet; Nicolas Cagnard; Darragh Duffy; Michael Dussiot; Marie-Louise Frémond; Marco Gattorno; Flavia Guillem; Naoki Kitabayashi; Fabrice Porcheray; Frederic Rieux-Laucat; Luis Seabra; Carolina Uggenti; Stefano Volpi; Leo A H Zeef; Marie-Alexandra Alyanakian; Jacques Beltrand; Anna Monica Bianco; Nathalie Boddaert; Chantal Brouzes; Sophie Candon; Roberta Caorsi; Marina Charbit; Monique Fabre; Flavio Faletra; Muriel Girard; Annie Harroche; Evelyn Hartmann; Dominique Lasne; Annalisa Marcuzzi; Bénédicte Neven; Patrick Nitschke; Tiffany Pascreau; Serena Pastore; Capucine Picard; Paolo Picco; Elisa Piscianz; Michel Polak; Pierre Quartier; Marion Rabant; Gabriele Stocco; Andrea Taddio; Florence Uettwiller; Erica Valencic; Diego Vozzi; Gunther Hartmann; Winfried Barchet; Olivier Hermine; Brigitte Bader-Meunier; Alberto Tommasini; Yanick J Crow
Journal:  Nat Commun       Date:  2017-12-19       Impact factor: 14.919

6.  Structure of acid deoxyribonuclease.

Authors:  Armando Varela-Ramirez; Jan Abendroth; Adrian A Mejia; Isabelle Q Phan; Donald D Lorimer; Thomas E Edwards; Renato J Aguilera
Journal:  Nucleic Acids Res       Date:  2017-06-02       Impact factor: 16.971

Review 7.  Deoxyribonucleases and Their Applications in Biomedicine.

Authors:  Lucia Lauková; Barbora Konečná; Ľubica Janovičová; Barbora Vlková; Peter Celec
Journal:  Biomolecules       Date:  2020-07-11

8.  Biogenesis and proteolytic processing of lysosomal DNase II.

Authors:  Susumu Ohkouchi; Masahiro Shibata; Mitsuho Sasaki; Masato Koike; Paul Safig; Christoph Peters; Shigekazu Nagata; Yasuo Uchiyama
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.